HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effects of erucic acid therapy on Japanese patients with X-linked adrenoleukodystrophy.

Abstract
Ten Japanese boys with childhood adrenoleukodystrophy (ALD), one adult patient with adrenomyeloneuropathy (AMN), and two presymptomatic ALD boys were treated with dietary erucic acid (C22:1) for more than 12 months; except in a case of childhood ALD patient who died 7 months after beginning erucic acid therapy. During erucic acid therapy, the serum levels of very long-chain fatty acid (VLCFA) (C24:0/C22:0) decreased within 1-2 months in all patients, and these levels in four of the patients decreased to the normal range. Neurological examination and MRI findings in all 10 of the childhood ALD patients showed progression of the disease while they were receiving the dietary therapy. However, the mean interval between the onset of awkward gait and a vegetative state in diet-treated patients was significantly longer than that in the untreated patients. One AMN patient showed slight improvement of spastic gait and lessened pain in the lower limbs due to spasticity. The two presymptomatic ALD boys remained intact on clinical examination and on MRI findings for 38 and 23 months, respectively, after starting the diet.
AuthorsJ Asano, Y Suzuki, S Yajima, K Inoue, N Shimozawa, N Kondo, M Murase, T Orii
JournalBrain & development (Brain Dev) 1994 Nov-Dec Vol. 16 Issue 6 Pg. 454-8 ISSN: 0387-7604 [Print] Netherlands
PMID7694994 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Erucic Acids
  • Fatty Acids
Topics
  • Adolescent
  • Adrenoleukodystrophy (drug therapy)
  • Adult
  • Age Factors
  • Child
  • Child, Preschool
  • Diagnosis, Differential
  • Diet Therapy
  • Erucic Acids (therapeutic use)
  • Fatty Acids (metabolism)
  • Follow-Up Studies
  • Humans
  • Japan
  • Magnetic Resonance Imaging
  • Male
  • Motor Activity
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: